Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond J Lim

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Lung Cancer and Immunity MarkersRaymond J Lim, Bin Liu, Kostyantyn Krysan, et al.
STAR Protocols|May 14, 2026
Protocol for mapping tumor infiltration by murine T cells using multiplex immunofluorescenceRaymond J Lim, Camelia Dumitras, Kostyantyn Krysan, et al.
Molecular Cancer Therapeutics|November 19, 2024
Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung CancerMichael S Oh, Camelia Dumitras, Ramin Salehi-Rad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 inductionXin Zhao, Bin Liu, William N William, et al.
Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burdenRamin Salehi-Rad, Rui Li, Linh M Tran, et al.
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
Open Forum Infectious Diseases|November 18, 2020
Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist TherapyKristin Schwab, Sepehr Hamidi, Augustine Chung, et al.
Journal for Immunotherapy of Cancer|June 25, 2026
FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancerJensen Abascal, Camelia Dumitras, Linh M Tran, et al.
Cell Reports. Medicine|March 22, 2024
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancerRaymond J Lim, Ramin Salehi-Rad, Linh M Tran, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2020
Lung Cancer and Immunity MarkersRaymond J Lim, Bin Liu, Kostyantyn Krysan, et al.
STAR Protocols|May 14, 2026
Protocol for mapping tumor infiltration by murine T cells using multiplex immunofluorescenceRaymond J Lim, Camelia Dumitras, Kostyantyn Krysan, et al.
Molecular Cancer Therapeutics|November 19, 2024
Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung CancerMichael S Oh, Camelia Dumitras, Ramin Salehi-Rad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 inductionXin Zhao, Bin Liu, William N William, et al.
Nature Medicine|April 27, 2023
Multi-organ landscape of therapy-resistant melanomaSixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burdenRamin Salehi-Rad, Rui Li, Linh M Tran, et al.
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
Open Forum Infectious Diseases|November 18, 2020
Occult Colonic Perforation in a Patient With Coronavirus Disease 2019 After Interleukin-6 Receptor Antagonist TherapyKristin Schwab, Sepehr Hamidi, Augustine Chung, et al.
Journal for Immunotherapy of Cancer|June 25, 2026
FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancerJensen Abascal, Camelia Dumitras, Linh M Tran, et al.
Cell Reports. Medicine|March 22, 2024
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancerRaymond J Lim, Ramin Salehi-Rad, Linh M Tran, et al.
Pageof 2